Category Archives: Cell Therapy

Splint- Cell Therapy (Original Mix) Drumstep. Download for free here: soundcloud.com This is my new channel. Please comment and, above all, share- you have no idea how much it helps. facebook.com/splint.uk soundcloud.com/cyklopsmk7 twitter.com/SamHarris_EBFrom:SplintTVukViews:0 0ratingsTime:05:39More inMusic Here is the original post: Splint- Cell Therapy (Original Mix) - Video … Continue reading →

GULF SHORES, Ala., Dec. 4, 2012 /PRNewswire/ --More than 75 percent of amyotrophic lateral sclerosis (ALS) patients who received neural reprogrammed stem cell therapy have shown a positive response to the procedure. The groundbreaking technique was introduced to the United States this year by Precision StemCell (http://www.precisionstemcell.com), an outpatient imaging and image-guided treatment facility located in Gulf Shores, Ala. The procedure is performed by Dr. Jason R. Williams, a board-certified radiologist with extensive training in image-guided procedures. Under his care, 14 out of 18 patients diagnosed with ALS, also known as Lou Gehrig's disease, have shown signs of recovery. "The improvements are mild, with patients reporting improved movement, breathing and speech, but we still have a long way to go," Dr. Williams stated. "Only time will tell how this therapy will affect the patients' long-term prognosis." In Precision StemCell's neural reprogrammed stem cell therapy, fat-derived stem cells are injected into the spine of the patient. Dr. Williams uses a drug called selegeline, which has been shown to be a pre-inducer of adipose-derived stem cells into neural-like cells. Dr. Williams contends that the therapy is probably one of the largest advances seen in ALS therapy. "Before we started this therapy, I … Continue reading →

.Rejuvenare Stem Cell Therapy 888-988-5456 Rejuvenare Autologous Adult Stem Cell Therapy welcome video asks and answers questions on whether someone is a candidate for stem cell therapy. More can be found at http://www.rejuvenare.comFrom:rejuvenareViews:2 0ratingsTime:01:01More inPeople Blogs See more here: .Rejuvenare Stem Cell Therapy 888-988-5456 - Video … Continue reading →

BOCA RATON, Fla.--(BUSINESS WIRE)-- Akron Biotechnology, LLCs Quality Management System was registered on November 30th, 2012 on the requirements of ISO 9001:2008 standards by BSI Group America Inc. This ISO Certification emphasizes Akron Biotechs commitment to quality and meeting their customers needs and expectations. It covers all relevant functions of the Company: development, production, storage and distribution of Akron Biotechs products, i.e. cryopreservation media, recombinant proteins, media supplements, scaffolds and cell culture systems. "This is an important step in our commitment to quality standards that will continue to enhance our products and services. We are looking forward to building upon this base towards a stronger foundation of excellence and compliance as we develop innovative products within our pipeline." said Claudia Zylberberg, PhD, Akrons President and CEO. She further stated We are committed to providing our customers with the unique ability to seamlessly transition from R&D to pre-clinical and clinical development with minimal change control in order for them to focus on their clinical outcome. About ISO 9001:2008 - Quality Management System ISO 9001:2008 is one of the most widely used management systems related to quality standards and ensuring that a company is meeting the needs of customers and regulatory requirements. … Continue reading →

WALTHAM, Mass.--(BUSINESS WIRE)-- Histogenics Corp., a biologics company that combines cell therapy and tissue engineering technologies to develop highly innovative products primarily for orthopaedic tissue repair and regeneration, today announced the appointment of Kevin L. Rakin to its Board of Directors. Mr. Rakin has over 20 years of experience in the biotechnology industry and most recently served as President of Regenerative Medicine at Shire plc. We are very pleased to welcome Kevin to the Histogenics Board of Directors. His broad experience in biotechnology and regenerative medicine over a 20 year career will be extremely valuable during this exciting time for the company, said Patrick ODonnell, President and Chief Executive Officer of Histogenics. We believe that Kevins experience with regenerative medicine treatments and understanding of niche markets will help us advance the clinical development program of NeoCart and prepare it for commercialization. Kevin Rakin was most recently the President of Regenerative Medicine at Shire plc, a leading specialty biopharmaceutical company. Prior to joining Shire, Mr. Rakin served as the Chairman and CEO of Advanced BioHealing (ABH) from 2007 until its acquisition by Shire for $750 million in June 2011. Before this, he served as the interim CEO of ABH and executive-in-residence … Continue reading →

Cell therapy may be effective against arthritis of fingers, says A.J. Farshchian MD from the Center for regenerative medicine. (PRWEB) December 03, 2012 A very common type of arthritis that we encounter here is Osteoarthritis of fingers. This is even becoming more common no thanks to advancements in technology. (use of computer keyboard or videogames or certain pocket organizers and cell phones) Repetitive motion is most likely the number one cause of osteoarthritis of fingers, common sign of osteoarthritis in the fingers is a knobby bony deformity at the smallest joint of the end of the fingers. This is called Heberden's node. The bony deformity is a result of the bone spurs or osteophytes from the osteoarthritis in that joint. This deformity limits the range of motion of the joint. Typically is not painful but sometimes patient may experience severe pain in the fingers. The Center for Regenerative Medicine in Miami, Florida concentrates on helping arthritic and injured people to get back to a functional level of life and their activities using non-surgical techniques and Orthopedic medicine. The center's expertise is in treatment of conditions of spine, knees, shoulders and other cartilage damages. They have developed non-surgical and rehabilitation techniques … Continue reading →

Aida Wong - ZLL-V Sheep Placenta Anti Aging Satisfied Customer Aida :拥有健康=拥有全世界。 http://www.zell-v.com We specialise in cell therapy products for anti aging. we are supported by an international medical board of practitioners, biologist and wellness professionals.From:zellvsheepplacentaViews:6 0ratingsTime:01:34More inHowto Style The rest is here: Aida Wong - ZÉLL-V Sheep Placenta Anti Aging Satisfied Customer - Video … Continue reading →

Metastatic melanoma patient discusses how T-cell therapy saved her life Nicho Bourque, a metastatic melanoma patient, was the first MD Anderson clinical trial patient to receive a new form of adoptive T-cell therapy, called T-cell therapy with dendritic cells. Learn about her experience with the treatment. Bourque was under the care of Nicholas Papadopoulos, MDFrom:mdandersonorgViews:0 0ratingsTime:04:22More inScience Technology Original post: Metastatic melanoma patient discusses how T-cell therapy saved her life - Video … Continue reading →

Company's ability to do something nobody has done before confirms world-leader status. Scottsdale, AZ (PRWEB) November 30, 2012 In the companys news yesterday, International Stem Cell Corp. has achieved a critical milestone towards the clinical development of its non-embryonic stem cell therapy. Through much dedication and hard work, the companys research and development team has created the worlds first human clinical-grade stem cell lines that can be immune-match to millions of individuals. ISCOs existing research-grade parthenogenetic stem cell lines, one of which may be an immune-match to approximately 70 million people, are being used in pre-clinical development. ISCO is now in a position to conduct clinical trials in the United States. Weve been working diligently for three years to perfect this technology, which was first developed by our scientific founder, Dr. Elena Revazova in Moscow, and Im excited to report that we have been able to derive new stem cell lines in the United States under the US and California regulatory frameworks. Im optimistic that the new parthenogenetic stem cell lines, by providing a potentially unlimited supply of cells and tissue for transplantation, will be of great benefit to the medical community and patients world-wide, stated Dr. Semechkin, CEO and … Continue reading →

"Achilles Tendinitis is now being treated using Regenerative Medicine and Cell Therapy," according to Dr. Farshchian , the medical director for The Center for Regenerative Medicine. (PRWEB) November 30, 2012 Achilles tendonitis refers to irritation and inflammation of the Achilles tendon which is located in the back of the ankle. Pain and swelling are typical symptoms, but over the long run the tendon can weaken and rupture this is a serious matter since it may cause chronic pain and disability. Typically patients experience most of the pain during running and jumping. Changes in footwear and training schedules as reported by the above patient could be a contributory factor to development Achilles tendinitis. The Center for Regenerative Medicine in Miami, Florida concentrates on helping arthritic and injured people to get back to a functional level of life and their activities using non-surgical techniques and Orthopedic medicine. The center's expertise is in treatment of conditions of spine, knees , shoulders , and other cartilage damages. They have developed non-surgical and rehabilitation techniques focused on treatment and management of joint pain. Their team includes health professionals organized around a central theme. Their wbsite is http://www.arthritisusa.net Marty Eugene http://www.arthritisusa.net 305 8668384 Email Information See … Continue reading →